Rosalind Advisors Inc. Invests $1.49 Million in Alpha Cognition, Inc. (NASDAQ:ACOG)

Rosalind Advisors Inc. acquired a new position in Alpha Cognition, Inc. (NASDAQ:ACOG - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund acquired 252,753 shares of the company's stock, valued at approximately $1,489,000. Alpha Cognition accounts for 0.7% of Rosalind Advisors Inc.'s holdings, making the stock its 22nd largest position. Rosalind Advisors Inc. owned approximately 1.58% of Alpha Cognition as of its most recent SEC filing.

Wall Street Analyst Weigh In

Separately, HC Wainwright initiated coverage on Alpha Cognition in a report on Tuesday, March 18th. They issued a "buy" rating and a $20.00 price objective for the company.

Alpha Cognition Stock Performance

NASDAQ:ACOG traded up $0.04 during mid-day trading on Wednesday, hitting $5.52. 21,707 shares of the company's stock were exchanged, compared to its average volume of 80,200. Alpha Cognition, Inc. has a one year low of $4.66 and a one year high of $7.00. The stock has a market cap of $88.43 million, a P/E ratio of -2.16 and a beta of 2.50. The company has a fifty day moving average price of $5.88.

Alpha Cognition Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.